Matches in Nanopublications for { ?s ?p "[Pharmacological modulation of the renal endogenous reparative process (that is, with angiotensin-converting enzyme inhibitors and AT1 angiotensin II receptor blockers), as well as future therapeutic strategies targeted to the renopoietic system, offers interesting perspectives for the management of hypertensive nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Pharmacological modulation of the renal endogenous reparative process (that is, with angiotensin-converting enzyme inhibitors and AT1 angiotensin II receptor blockers), as well as future therapeutic strategies targeted to the renopoietic system, offers interesting perspectives for the management of hypertensive nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Pharmacological modulation of the renal endogenous reparative process (that is, with angiotensin-converting enzyme inhibitors and AT1 angiotensin II receptor blockers), as well as future therapeutic strategies targeted to the renopoietic system, offers interesting perspectives for the management of hypertensive nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP350207.RAYXfOJRZ0xd7Xu9iJlhkVej4qGFyAYBkgEzGS4cEwEV0130_assertion description "[Pharmacological modulation of the renal endogenous reparative process (that is, with angiotensin-converting enzyme inhibitors and AT1 angiotensin II receptor blockers), as well as future therapeutic strategies targeted to the renopoietic system, offers interesting perspectives for the management of hypertensive nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350207.RAYXfOJRZ0xd7Xu9iJlhkVej4qGFyAYBkgEzGS4cEwEV0130_provenance.
- NP229655.RAlqoOg4ooQIZIK_8IIBGrNCxlgqiJ_HkWfg0pGsl8FnA130_assertion description "[Pharmacological modulation of the renal endogenous reparative process (that is, with angiotensin-converting enzyme inhibitors and AT1 angiotensin II receptor blockers), as well as future therapeutic strategies targeted to the renopoietic system, offers interesting perspectives for the management of hypertensive nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP229655.RAlqoOg4ooQIZIK_8IIBGrNCxlgqiJ_HkWfg0pGsl8FnA130_provenance.
- NP1089307.RAOumU6rcO-zMfvy7I-evDJLgANoBSn7cFm3EfMq5wytM130_assertion description "[Pharmacological modulation of the renal endogenous reparative process (that is, with angiotensin-converting enzyme inhibitors and AT1 angiotensin II receptor blockers), as well as future therapeutic strategies targeted to the renopoietic system, offers interesting perspectives for the management of hypertensive nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089307.RAOumU6rcO-zMfvy7I-evDJLgANoBSn7cFm3EfMq5wytM130_provenance.
- NP1089308.RALJu2EgvopYi2FR4-QTpracHSUB5krvHuaa2BtuqCKc8130_assertion description "[Pharmacological modulation of the renal endogenous reparative process (that is, with angiotensin-converting enzyme inhibitors and AT1 angiotensin II receptor blockers), as well as future therapeutic strategies targeted to the renopoietic system, offers interesting perspectives for the management of hypertensive nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089308.RALJu2EgvopYi2FR4-QTpracHSUB5krvHuaa2BtuqCKc8130_provenance.